Share

Pfizer-BioNTech to study variant-specific booster for Covid vaccine

Pfizer and BioNTech said on Thursday they are testing a third dose of their Covid-19 vaccine to better understand the immune response against new variants of the virus. CNBC's Meg Tirrell reports.
02:57
Thu, Feb 25 20217:11 AM EST